DSIP and Sleep Research: What the Evidence Shows

What did the original animal studies show?

In 1977, synthetic DSIP infused into rabbit brain ventricles enhanced delta and spindle EEG patterns.^{[1], [9]}

The experiment used 58 rabbits including controls under double-blind conditions. Later reviewers noted that some artificial DSIP analogues, but not DSIP itself, showed significant slow-wave sleep promotion in rabbits and rats.

What did human sleep studies find?

Results are mixed: early open or small studies were positive, while a double-blind crossover study and a later matched-pairs study found weak or non-significant effects.^{[3], [7], [6], [8]}

A 1981 study of six insomniacs reported longer sleep with sleep-promoting effects only in the second hour after injection. A 1987 placebo-controlled study of 14 insomniacs reported efficacy. A 1987 crossover study found no significant differences versus baseline or placebo, and a 1992 study of 16 patients concluded short-term treatment was unlikely to be of major benefit.

See also: details on each human study

What is the difference between endogenous DSIP and administered DSIP?

Endogenous research asks whether DSIP occurs naturally and what it does; exogenous research gives synthetic DSIP and measures outcomes.^[9]

DSIP-like immunoreactivity has been found in several tissues, but immunohistochemistry alone does not prove the peptide is naturally released, and its natural biological activity remains obscure.

What are the methodological limitations?

Small samples, short treatment periods, intravenous dosing at a single reported dose level, varied designs, and no independent large replication.^{[3], [7], [8]}

The human studies identified here enrolled between 6 and 16 participants (where reported), were conducted in the 1980s and early 1990s, and used different designs, which limits comparison.